Space startup Varda raises $187 million in funding to make drugs in orbit

Space startup Varda raises 7 million in funding to make drugs in orbit


Pavlo Gonchar | Lightrocket | Getty Images

Space startup Varda announced on Thursday that it has raised $187 million in Series C funding, led by venture capital firms Natural Capital and Shrug Capital, to continue advancing drug manufacturing in space.

The latest round included participation from Peter Thiel, Lux Capital, Khosla Ventures and Caffeinated Capital. It brought the total capital Varda’s raised to $329 million.

“By expanding, we can support work on more complex molecules and ultimately increase cadence to achieve the turnaround times the pharmaceutical industry expects,” Chief Science Officer Adrian Radocea said in a press release Thursday.

Varda’s main mission is to launch and return drugs made in space. The startup has said the medicines crystallize differently in orbit due to the gravity differences, which would allow it to complete drugs that are currently difficult to manufacture.

In 2024, the space startup’s W-Series 1 capsule received FAA approval to return after successfully creating the drug Ritonavir the previous year.

So far, Varda said the company has been able to complete three space launches. Now, a fourth is in orbit, and the company expects to launch a fifth by the end of the year. Varda’s system uses Rocket Lab’s Photon spacecraft for its operation and adds its manufacturing module and a heatshield-protected capsule.

“With this capital, Varda will continue to increase our flight cadence and build out the pharmaceutical lab that will deliver the world’s first microgravity-enabled drug formulation,” said Varda CEO Will Bruey.

Varda Space Industries is the first company to process materials outside the International Space Station.

Recently, the space company has also operated a testbed for the U.S. government to use the W-series reentry vehicles to advance technology.

Varda said it has expanded into Huntsville, Alaska, and opened a laboratory in El Segundo, California, to begin work to crystallize more drugs.

“Our new lab space is an investment in our belief that in-space pharmaceutical manufacturing will drive the foundation of the orbital economy,” Radocea said.



Source

JPMorgan Chase says it will invest  billion into industries critical for national security
Business

JPMorgan Chase says it will invest $10 billion into industries critical for national security

Jamie Dimon, chief executive officer of JPMorgan Chase & Co., during a Bloomberg Television interview at the JPMorgan Chase & Co. Capital Markets conference in Paris, France, on Thursday, May 15, 2025. Cyril Marcilhacy | Bloomberg | Getty Images JPMorgan Chase on Monday said it is launching a decade-long plan to help finance and take […]

Read More
Airlines tell passengers to prepare for delays as government shutdown continues
Business

Airlines tell passengers to prepare for delays as government shutdown continues

The Hollywood Burbank Airport air traffic control tower stands in Burbank, California, on Oct. 6, 2025. Mario Tama | Getty Images Travelers should prepare for potential flight disruptions this holiday weekend as the government shutdown continues, a group representing the largest U.S. airlines said Friday. Air traffic controller shortages this week delayed flights at some […]

Read More
NBA Commissioner Adam Silver says ‘we’d love to bring a WNBA game’ to China
Business

NBA Commissioner Adam Silver says ‘we’d love to bring a WNBA game’ to China

MACAO — NBA Commissioner Adam Silver said Friday the WNBA could be next to play games in China.  Silver spoke exclusively with CNBC courtside from the first of two NBA games in Macao.  “We have to get through a new collective bargaining agreement with our players,” he said. “But once we do, there’s so much […]

Read More